๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Merkel Cell Carcinoma

A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors NCT07115043Phase 1, Phase 213 sites๐Ÿ“ Grand Rapids๐Ÿ“ St Louis๐Ÿ“ Pittsburgh AstraZeneca ยท Tests: AZD6750, rilvegostomig Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors NCT07006727Phase 18 sites๐Ÿ“ Iowa City๐Ÿ“ Boston๐Ÿ“ Royal Oak Novartis Pharmaceuticals ยท Tests: 225Ac-ETN029, 111In-ETN029 TIL Therapy in cSCC and MCC NCT07288073Phase 21 site๐Ÿ“ Boston Karam Khaddour, MD, MS ยท Tests: LN-145, Cyclophosphamide, Fludarabine, Interleukin-2 A First-in-Human Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of KUP-101A in Patients With Selected Advanced Solid Tumors NCT07600476Phase 13 sites๐Ÿ“ Munich๐Ÿ“ Wรผrzburg๐Ÿ“ Mรผnster Kupando GmbH ยท Tests: KUP-101A Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus NCT02479698Phase 21 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Allogeneic BK-specific Cytotoxic T-lymphocytes, Laboratory Biomarker Analysis Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rฮฑ Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer NCT05267626Phase 1, Phase 217 sites๐Ÿ“ Miami๐Ÿ“ Grand Rapids๐Ÿ“ Minneapolis Aulos Bioscience, Inc. ยท Tests: AU-007, Aldesleukin, Avelumab, Nivolumab MEM-288 Oncolytic Virus Alone and in Combination With Standard of Care Therapy in Advanced Solid Tumors NCT05076760Phase 12 sites๐Ÿ“ Tampa๐Ÿ“ Durham Memgen, Inc. ยท Tests: MEM-288 Intratumoral Injection, Nivolumab, Docetaxel A Study of CRD3874-SI in People With Solid Tumors NCT06021626Phase 17 sites๐Ÿ“ Basking Ridge๐Ÿ“ Middletown๐Ÿ“ Montvale Memorial Sloan Kettering Cancer Center ยท Tests: CRD3874 Neoadjuvant Merkel Cell Carcinoma Therapy (Tx) With the PD-1 Inhibitor Cemiplimab NCT07387198Phase 214 sites๐Ÿ“ Heidelberg๐Ÿ“ Mannheim๐Ÿ“ Tรผbingen Institut fรผr Klinische Krebsforschung IKF GmbH at Krankenhaโ€ฆ ยท Tests: Cemiplimab 350 mg i.v. on day 1 of every 21 days cycle for 2 cycles, Placebo NaCl 0.9% solution i.v. on day 1 of every โ€ฆ Validation of in Vitro Method for Anti-MCPyV Immunotherapy on Patients With Cutaneous Merkel Cell Carcinoma NCT06780475n/a1 site๐Ÿ“ Boulogne-Billancourt Assistance Publique - Hรดpitaux de Paris Studies of Dermatologic Diseases Biospecimen Acquisition Protocol NCT02471352n/a1 site๐Ÿ“ Bethesda National Institute of Arthritis and Musculoskeletal and Skiโ€ฆ Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer NCT05896839Phase 1, Phase 226 sites๐Ÿ“ La Jolla๐Ÿ“ Los Angeles๐Ÿ“ Los Angeles National Cancer Institute (NCI) ยท Tests: Biopsy Procedure, Biospecimen Collection, Computed Tomography, Ipilimumab, Kidney Biopsy IFx-Hu2.0 As An Adjunctive Therapy To Pembrolizumab In Advanced Or Metastatic Merkel Cell Carcinoma (MCC) NCT06940440Phase 12 sites๐Ÿ“ Tampa๐Ÿ“ Madison TuHURA Biosciences, Inc. ยท Tests: IFx-Hu2.0, Pembrolizumab Neoadjuvant Nivolumab and Relatlimab in Merkel Cell Carcinoma NCT06151236Phase 21 site๐Ÿ“ Wollstonecraft Melanoma Institute Australia ยท Tests: Nivolumab 240 mg / Relatlimab 80 mg in a fixed dose combination Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis NCT06047379Phase 1, Phase 28 sites๐Ÿ“ Beverly Hills๐Ÿ“ Glendale๐Ÿ“ Los Angeles Neonc Technologies, Inc. ยท Tests: NEO212 Oral Capsule, Ipilimumab, Pembrolizumab, Nivolumab, Regorafenib Studying Off Label Insurance Coverage for Patients With Cutaneous Cancers a "Filter" Observational Study NCT07215988n/a1 site๐Ÿ“ Columbus Ohio State University Comprehensive Cancer Center ยท Tests: Non-Interventional Study Neoadjuvant Cemiplimab in Newly Diagnosed or Recurrent Stage I-II Merkel Cell Carcinoma and Locoregionally Advanced Cutaneous Squamous Cell Carcinoma NCT04975152Phase 11 site๐Ÿ“ Tampa H. Lee Moffitt Cancer Center and Research Institute ยท Tests: Cemiplimab-Rwlc A Study of VET3-TGI in Patients With Solid Tumors NCT06444815Phase 17 sites๐Ÿ“ Los Angeles๐Ÿ“ Orange๐Ÿ“ Miami KaliVir Immunotherapeutics ยท Tests: VET3-TGI, Atezolizumab Neoadjuvant PD-1 Blockade in Resectable Merkel Cell Carcinoma NCT05496036Phase 21 site๐Ÿ“ Philadelphia Abramson Cancer Center at Penn Medicine ยท Tests: Pembrolizumab Electrochemotherapy (ECT) in Patients With Primary Visceral Tumors and/or Secondary Visceral Localizations, of Any Histotype NCT06753136NA1 site๐Ÿ“ Padova Istituto Oncologico Veneto IRCCS ยท Tests: percutaneous, laparoscopic or laparotomy lesion electrochemotherapy French National Database of Rare Dermatological Cancers NCT03210935n/a34 sites๐Ÿ“ Dijon๐Ÿ“ Le Mans๐Ÿ“ Pierre-Bรฉnite University Hospital, Lille Hypofractionated Radiation Therapy for Merkel Cell Carcinoma NCT05100095Phase 21 site๐Ÿ“ Houston M.D. Anderson Cancer Center ยท Tests: Radiation therapy At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer NCT05969860Phase 22 sites๐Ÿ“ Jacksonville๐Ÿ“ Grand Forks Mayo Clinic ยท Tests: Clinical Encounter, Home Health Encounter, Quality-of-Life Assessment, Questionnaire Administration A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors NCT07749586Phase 1, Phase 24 sites๐Ÿ“ New York๐Ÿ“ Huntersville๐Ÿ“ San Antonio Arvinas Inc. ยท Tests: ARV-6723, Pembrolizumab, SOC EMLA Topical Cream for Treatment of Pain in Patients Receiving Intra-Dermal Technetium 99 Injections for Lymphoscintigraphy for Skin Cancers NCT06223659Phase 21 site๐Ÿ“ Columbus Ohio State University Comprehensive Cancer Center ยท Tests: Eutectic Mixture of Local Anesthetics, Placebo Administration, Questionnaire Administration A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors NCT05592626Phase 1, Phase 219 sites๐Ÿ“ Sacramento๐Ÿ“ Celebration๐Ÿ“ Miami Marengo Therapeutics, Inc. ยท Tests: STAR0602, Irinotecan (Camptosar), Docetaxel (Taxotere) Sentinel Lymph Node Biopsy in Ocular Surface and Adnexal Cancers NCT05797415n/a1 site๐Ÿ“ Roma Fondazione Policlinico Universitario Agostino Gemelli IRCCS ยท Tests: Sentinel Lymph Node Biopsy Personalized Neoantigen Peptide-Based Vaccine in Combination With Pembrolizumab for Treatment of Advanced Solid Tumors NCT05269381Phase 1, Phase 21 site๐Ÿ“ Jacksonville Mayo Clinic ยท Tests: Cyclophosphamide, Neoantigen Peptide Vaccine, Pembrolizumab, Sargramostim, Biospecimen Collection Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors NCT06814496Phase 1, Phase 23 sites๐Ÿ“ Gilbert๐Ÿ“ Tucson๐Ÿ“ Seattle University of Arizona ยท Tests: Tarlatamab, Concurrent Radiation Therapy, Sequential Radiation therapy Placebo-Controlled Trial of IFx-Hu2.0 Followed By Pembrolizumab In Checkpoint Inhibitor Naรฏve Participants With Advanced Or Metastatic Merkel Cell Carcinoma NCT06947928Phase 2, Phase 318 sites๐Ÿ“ Los Angeles๐Ÿ“ San Francisco๐Ÿ“ Stanford TuHURA Biosciences, Inc. ยท Tests: IFx-Hu2.0, Placebo, Pembrolizumab
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy